HSBC Holdings’s Guardant Health GH Stock Holding History

HSBC Holdings’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,100	Closed	-$212K	–	3332
2021 Q4	$212K	Buy	+2,100	New	+$217K	﹤0.01%	3004

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

HSBC Holdings's GH Position: Q2 2026 in Review

HSBC Holdings increased its Guardant Health (GH) stake by 7.2% in Q2 2026, buying an estimated $776K and bringing the position to 105,979 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #832.

HSBC Holdings first reported a position in GH in Q3 2020 and has held it in 23 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

HSBC Holdings held 105,979 shares of Guardant Health worth $15.9M as of Q2 2026.
HSBC Holdings bought 7,136 Guardant Health shares in Q2 2026, an estimated $776K.
Guardant Health made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #832 holding.
HSBC Holdings first reported a position in Guardant Health in Q3 2020 and has held it in 23 quarters since.
600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.